PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
1943731-4	1991	With norgestrel administration, HTGL activity increased from 79 +/- 19 to 109 +/- 24 nmol/min/mL (P less than .05); HDL cholesterol decreased from 64 +/- 17 to 43 +/- 7 mg/dL (P less than .05); HDL2 cholesterol decreased from 21 +/- 17 to 6 +/- 5 mg/dL (P less than .05); and HDL3 cholesterol concentration decreased from 43 +/- 8 to 38 +/- 8 mg/dL (P less than .05).	Norgestrel	5-15	junctophilin 3	Homo sapiens	194-198	
3132043-3	1988	Other effects, however, were apparently dependent on the type of progestin, with the androgenically potent agent dl-norgestrel causing dramatic increases in low-density lipoprotein (LDL)-cholesterol and the ratio of low-density to high-density lipoprotein (HDL) and decreases in HDL, particularly HDL2, and apoprotein Al.	Norgestrel	113-126	junctophilin 3	Homo sapiens	297-301	
3132043-6	1988	In contrast to the findings of the previous study, norgestrel lowered LDL and produced less substantial decreases in HDL and HDL2.	Norgestrel	51-61	junctophilin 3	Homo sapiens	125-129	
6401927-6	1983	HDL2b increased with the norethindrone oral contraceptive and declined with the norgestrel oral contraceptive.	Norgestrel	80-90	junctophilin 3	Homo sapiens	0-4